Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Solid Tumor Cancer: early-phase trial registry
9 of 11 indexed Solid Tumor Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 9 currently recruiting · #1,577 of 28,707 conditions by registered trial count
Solid Tumor Cancer: 11 US clinical trials tracked, 9 recruiting.
Solid Tumor Cancer is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is Avenzo Therapeutics, running 2 of these trials.
Enrollment posture brief
Registry condition solid-tumor-cancer
OPEN 9 | RECR 82% | LATE 0 | EARLY 6 | RANK #1577 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Gynecologic Cancers (82% recruiting · 11 trials)
Solid Tumor Cancer lists 9 open slots (82% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Solid Tumor Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Solid Tumor Cancer is recruiting above its size-band peers.
9 of 11 indexed trials (81.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Solid Tumor Cancer research.
Avenzo Therapeutics accounts for 2 of 11 trials (18.2%). 9 distinct sponsors appear on at least one study for this condition label.
-
Typical Solid Tumor Cancer enrolment sits around 100 participants.
Median target enrolment is 100 among the 11 trials that report a genuine target (sentinel values excluded). 5 of those (45.5%) plan for fewer than 100 participants.
-
Solid Tumor Cancer research is mostly interventional.
9 interventional and 2 observational studies make up this index (81.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Collection of Multimodal Data (Including Clinical Data, Imaging Data and Omics Data) in Oncology
OWKIN
NCT06625203
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Avenzo Therapeutics
NCT07038343
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Conjupro Biotherapeutics
NCT07424547
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Avenzo Therapeutics
NCT07193511
Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
Fred Hutchinson Cancer Center
NCT06802172
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
NCT04354064
A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer
Memorial Sloan Kettering Cancer Center
NCT07117461
Feasibility and Acceptability of the Remote Oncology Symptom Assessment Application
University of Pittsburgh
NCT07218874
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Pilatus Biosciences
NCT07337525
SB-743921 In Patients With Solid Tumors
GlaxoSmithKline
NCT00136513
Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid Tumors
GlaxoSmithKline
NCT00085878
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
Top Sponsors
Named interventions
Most-linked intervention names on Solid Tumor Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Solid Tumor Cancer trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Solid Tumor Cancer page
11 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 9 Solid Tumor Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Avenzo Therapeutics sponsors the most Solid Tumor Cancer trials on record, review their full trial history before evaluating a specific study. See Avenzo Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Solid Tumor Cancer condition card totals 11 registered trials; most-linked intervention SB-743921; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.